An underground market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.
Investigational Drug Gaining Popularity Online
The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning properties. Viewers are encouraged to contact these profiles directly for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Additionally, a robust trade exists on Telegram, where groups with numerous of participants share comparison photos, injection guides and claims of next-day UK delivery. Vendors promote the drug there before directing customers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Experts Express Concerns
However, physicians and pharmacists have cautions that the distribution of what is still an unapproved medication in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.
Some professionals said the demand for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the British medical regulations.
Several content creators try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate medicines, marketing, and customer regulations, risking fines, legal action or imprisonment.
Platform Reaction and Content Removal
According to TikTok, the platform has taken down problematic material and prohibited associated keywords and query recommendations. The company stated it was committed to maintaining the service secure and investing in strengthening compliance measures.
Digital Marketplace Operations
Investigations also found communities with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, glowing reviews and detailed instructions for mixing or administering at home.
After minutes of joining one community, a vendor shared WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about weight, health issues or past usage.
Product Details and Costs
Inside these communities, posts show dark colored packages with postal service labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors usually sold at 160 pounds for 20 milligrams. When asked how much time a pen should last, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service said it regularly monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering substances they cannot confirm. Even if the science behind retatrutide is valid, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said.
Her team has previously encountered individuals harmed by personal administration from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Position
A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet approved … may subject patients to possibly serious medical dangers”.
